1-8 of 8
Giancarlo Castaman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness of Voncento Prophylaxis Versus On-Demand Treatment in von Willebrand Disease in the United Kingdom

Michele R Wilson, Giancarlo Castaman, William Thomas, Carolyn M Millar, Gines Escolar, Wolfgang A. Miesbach, Cheryl L McDade, Radovan Tomic, Songkai Yan
Journal: Blood Advances
Blood Adv bloodadvances.2024014376.
https://doi.org/10.1182/bloodadvances.2024014376
Published: 2024
Journal Articles

Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice

Vincenzo La Mura, Vincenzo Cardinale, Raimondo De Cristofaro, Adriano De Santis, Giovanni Di Minno, Luca Fabris, Fabio Marra, Filomena Morisco, Flora Peyvandi, Maurizio Pompili, Cristina Santoro, Ezio Zanon, Giancarlo Castaman
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5725–5734.
https://doi.org/10.1182/bloodadvances.2024013750
Published: 2024
Journal Articles

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy

Clinical Trials & Observations
Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan U. Lattimore, Frank W. G. Leebeek, Wolfgang A. Miesbach, Michael Recht, Robert Gut, Ricardo Dolmetsch, Paul E. Monahan, Sandra Le Quellec, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5671–5679.
https://doi.org/10.1182/bloodadvances.2022008886
Published: 2023
Includes: Supplemental data
Journal Articles

The bleeding phenotype in people with nonsevere hemophilia

Fabienne R. Kloosterman, Anne-Fleur Zwagemaker, Catherine N. Bagot, Erik A. M. Beckers, Giancarlo Castaman, Marjon H. Cnossen, Peter W. Collins, Charles Hay, Michel Hof, Britta Laros-van Gorkom, Frank W. G. Leebeek, Christoph Male, Karina Meijer, Ingrid Pabinger, Susan Shapiro, Michiel Coppens, Karin Fijnvandraat, Samantha C. Gouw,
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4256–4265.
https://doi.org/10.1182/bloodadvances.2022007620
Published: 2022
Includes: Supplemental data
Journal Articles

Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors

Clinical Trials & Observations
Amy D. Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P. Wheeler, Guy Young, Silva Zupančić-Šalek, Johannes Oldenburg, Pratima Chowdary
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3422–3432.
https://doi.org/10.1182/bloodadvances.2021006403
Published: 2022
Includes: Supplemental data
Journal Articles

Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS

Luciano Baronciani, Ian Peake, Reinhard Schneppenheim, Anne Goodeve, Minoo Ahmadinejad, Zahra Badiee, Mohammad-Reza Baghaipour, Olga Benitez, Imre Bodó, Ulrich Budde, Andrea Cairo, Giancarlo Castaman, Peyman Eshghi, Jenny Goudemand, Wolf Hassenpflug, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W. G. Leebeek, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Renato Marino, Nikolas Nikšić, Florian Oyen, Cristina Santoro, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Eva M. K. Zetterberg, Jeroen Eikenboom, Augusto B. Federici, Flora Peyvandi
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2987–3001.
https://doi.org/10.1182/bloodadvances.2020003397
Published: 2021
Includes: Supplemental data
Journal Articles

Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D′D3 and D4 domains

Monica Sacco, Stefano Lancellotti, Mattia Ferrarese, Francesco Bernardi, Mirko Pinotti, Maira Tardugno, Erica De Candia, Leonardo Di Gennaro, Maria Basso, Betti Giusti, Massimiliano Papi, Giordano Perini, Giancarlo Castaman, Raimondo De Cristofaro
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3405–3415.
https://doi.org/10.1182/bloodadvances.2020002334
Published: 2020
Includes: Supplemental data
Journal Articles

Etranacogene dezaparvovec (AMT-061 phase 2b): normal/near normal FIX activity and bleed cessation in hemophilia B

Annette Von Drygalski, Adam Giermasz, Giancarlo Castaman, Nigel S. Key, Susan Lattimore, Frank W. G. Leebeek, Wolfgang Miesbach, Michael Recht, Alison Long, Robert Gut, Eileen K. Sawyer, Steven W. Pipe
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3241–3247.
https://doi.org/10.1182/bloodadvances.2019000811
Published: 2019
Includes: Supplemental data